rs774763657
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_004415.4(DSP):βc.5680_5683delβ(p.Ser1894LeufsTer34) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,870 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ).
Frequency
Genomes: not found (cov: 32)
Exomes π: 0.0000021 ( 0 hom. )
Consequence
DSP
NM_004415.4 frameshift
NM_004415.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.38
Genes affected
DSP (HGNC:3052): (desmoplakin) This gene encodes a protein that anchors intermediate filaments to desmosomal plaques and forms an obligate component of functional desmosomes. Mutations in this gene are the cause of several cardiomyopathies and keratodermas, including skin fragility-woolly hair syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 18 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 6-7582940-ACAGT-A is Pathogenic according to our data. Variant chr6-7582940-ACAGT-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 405232.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSP | NM_004415.4 | c.5680_5683del | p.Ser1894LeufsTer34 | frameshift_variant | 24/24 | ENST00000379802.8 | NP_004406.2 | |
DSP | NM_001008844.3 | c.3883_3886del | p.Ser1295LeufsTer34 | frameshift_variant | 24/24 | NP_001008844.1 | ||
DSP | NM_001319034.2 | c.4351_4354del | p.Ser1451LeufsTer34 | frameshift_variant | 24/24 | NP_001305963.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSP | ENST00000379802.8 | c.5680_5683del | p.Ser1894LeufsTer34 | frameshift_variant | 24/24 | 1 | NM_004415.4 | ENSP00000369129 | P2 | |
DSP | ENST00000418664.2 | c.3883_3886del | p.Ser1295LeufsTer34 | frameshift_variant | 24/24 | 1 | ENSP00000396591 | A2 | ||
DSP | ENST00000710359.1 | c.4351_4354del | p.Ser1451LeufsTer34 | frameshift_variant | 24/24 | ENSP00000518230 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251232Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135792
GnomAD3 exomes
AF:
AC:
3
AN:
251232
Hom.:
AF XY:
AC XY:
1
AN XY:
135792
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461870Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 727234
GnomAD4 exome
AF:
AC:
3
AN:
1461870
Hom.:
AF XY:
AC XY:
1
AN XY:
727234
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cardiomyopathy Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Nov 16, 2023 | This variant deletes 4 nucleotides in exon 24 of the DSP gene, creating a frameshift and premature translation stop signal in the last exon. The mutant transcript is expected to escape nonsense-mediated decay and be expressed as a protein product containing an altered C-terminal sequence. Although functional studies have not been reported, this variant is expected to disrupt the plakin repeat domains and downstream C-terminal sequence, which have been reported to be essential for interaction with intermediate filaments (PMID: 12101406, 12802069, 21756917). In addition, truncating variants occurring downstream of this variant are known to be disease-causing (for example, ClinVar variation ID: 199903, 222582). To our knowledge, this variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 3/251232 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of DSP function is a known mechanism of disease. Based on the available evidence, this variant is classified as Likely Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Sep 18, 2024 | The c.5680_5683del variant in DSP is predicted to cause a frameshift resulting in a premature stop codon at position 1927, leading to a truncated or absent protein. Heterozygous loss-of-function variants in the DSP gene is a well-established mechanism of disease for dilated cardiomyopathy (PMID 23137101, 27532257, 32046637, 32808748, and others) with a very strong level of evidence (PMID 30192042). It has a Grpmax Filtering Allele Frequency of 0.002% in control populations in the Genome Aggregation Database (gnomAD), and is neither sufficiently rare to provide evidence in favor of pathogenicity nor sufficiently common to provide evidence against pathogenicity. It has been previously reported in at least 2 apparently unrelated individuals with dilated cardiomyopathy and/or arrhythmogenic cardiomyopathy (PMID 38510230, CHEO internal data). This variant is listed in ClinVar (VCV000405232). The current evidence suggests that in addition to autosomal dominant inheritance, some variants in DSP can cause autosomal recessive cardiomyopathy (PMID 20301310, 31983221). Based on the above information, we categorize this variant as likely pathogenic. - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | May 04, 2022 | The DSP c.5680_5683delAGTC; p.Ser1894LeufsTer34 variant (rs774763657) is reported in the literature in an individual diagnosed with arrhythmogenic right ventricular cardiomyopathy (Ye 2019) and is reported as pathogenic/likely pathogenic in ClinVar (Variation ID: 405232). This variant is found on only three chromosomes in the Genome Aggregation Database (3/251,232 alleles), indicating it is not a common polymorphism. This variant results in a premature termination codon in the last exon of the DSP gene. While this may not lead to nonsense-mediated decay, it is expected to create a truncated protein missing the last 978 amino acids of the normal DSP protein. Truncating variants downstream of c.5680_5683delAGTC are reported in patients with cardiomyopathy and are considered disease-causing (Castelletti 2017, Fressart 2010). Based on available information, the c.5680_5683delAGTC variant is considered to be likely pathogenic. References: Castelletti S et al. Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation. Int J Cardiol. 2017 Dec 15;249:268-273. Fressart V et al. Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace. 2010 Jun;12(6):861-8. Ye JZ et al. Reevaluation of genetic variants previously associated with arrhythmogenic right ventricular cardiomyopathy integrating population-based cohorts and proteomics data. Clin Genet. 2019 Dec;96(6):506-514. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 16, 2024 | Frameshift variant predicted to result in protein truncation in a gene for which loss-of-function is a known mechanism of disease; Reported as part of a multi-database review of ARVC-related variants; no clinical information was provided (PMID: 31402444); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 11063735, 31402444) - |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Jan 08, 2024 | This variant deletes 4 nucleotides in exon 24 of the DSP gene, creating a frameshift and premature translation stop signal in the last exon. The mutant transcript is expected to escape nonsense-mediated decay and be expressed as a protein product containing an altered C-terminal sequence. Although functional studies have not been reported, this variant is expected to disrupt the plakin repeat domains and downstream C-terminal sequence, which have been reported to be essential for interaction with intermediate filaments (PMID: 12101406, 12802069, 21756917). In addition, truncating variants occurring downstream of this variant are known to be disease-causing (for example, ClinVar variation ID: 199903, 222582). To our knowledge, this variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 3/251232 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of DSP function is a known mechanism of disease. Based on the available evidence, this variant is classified as Likely Pathogenic. - |
Arrhythmogenic right ventricular dysplasia 8;C1854063:Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | This sequence change creates a premature translational stop signal (p.Ser1894Leufs*34) in the DSP gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 978 amino acid(s) of the DSP protein. This variant is present in population databases (rs774763657, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with DSP-related conditions. ClinVar contains an entry for this variant (Variation ID: 405232). This variant disrupts a region of the DSP protein in which other variant(s) (p.Thr2634Lysfs*4) have been determined to be pathogenic (PMID: 11063735). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 16, 2024 | The c.5680_5683delAGTC pathogenic mutation, located in coding exon 24 of the DSP gene, results from a deletion of 4 nucleotides at nucleotide positions 5680 to 5683, causing a translational frameshift with a predicted alternate stop codon (p.S1894Lfs*34). Alterations in DSP that result in haploinsufficiency or protein truncation have been reported in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) and dilated cardiomyopathy (DCM) (Fressart V et al. Europace. 2010;12(6):861-8; Elliott P et al. Circ Cardiovasc Genet. 2010;3(4):314-22; Quarta G et al. Circulation. 2011;123(23):2701-9; Garcia-Pavia P et al. Heart. 2011;97(21):1744-52; Rasmussen TB et al. Clin Genet. 2013;84(1):20-30; Pugh TJ et al. Genet Med. 2014;16(8):601-8). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
DSP-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 12, 2024 | The DSP c.5680_5683delAGTC variant is predicted to result in a frameshift and premature protein termination (p.Ser1894Leufs*34). This variant was reported in the heterozygous state in an individual with arrhythmogenic cardiomyopathy (Sanford et al. 2024. PubMed ID: 38510230). This variant is reported in 0.0087% of alleles in individuals of Latino descent in gnomAD. Frameshift variants in DSP are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Familial isolated arrhythmogenic right ventricular dysplasia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 21, 2023 | Variant summary: DSP c.5680_5683delAGTC (p.Ser1894LeufsX34) results in a premature termination codon and is predicted to cause a truncation of the encoded protein, which is a commonly known mechanism for disease. Although the variant is not predicted to cause absence of the protein through nonsense mediated decay, the variant is predicted to disrupt the last 978 amino acids in the protein sequence. Variants downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 251232 control chromosomes (gnomAD). To our knowledge, no occurrence of c.5680_5683delAGTC in individuals affected with Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. Five ClinVar submitters have assessed the variant since 2014: three classified the variant as likely pathogenic, and two as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at